SARS COV-2 infection |
Symptoms |
Body temperature [1 unit increase vs. Not applicable] |
Odds ratio: 2.550 (1.320-5.210)
§ |
Sun
|
|
|
SARS COV-2 infection |
Vital Signs |
Heart rate [1 unit increase vs. Not applicable] |
Odds ratio: 0.950 (0.920-0.990)
§ |
Sun
|
|
|
SARS COV-2 infection |
Vital Signs |
Respiration rate [1 unit increase vs. Not applicable] |
Odds ratio: 1.290 (1.070-1.590)
§ |
Sun
|
|
|
SARS COV-2 infection |
Vital Signs |
Diastolic blood pressure [1 unit increase vs. Not applicable] |
Odds ratio: 1.040 (1.000-1.090)
§ |
Sun
|
|
|
SARS COV-2 infection |
Symptoms |
Sore throat [Present vs. Not present] |
Odds ratio: 0.530 (0.220-1.250)
§ |
Sun
|
|
|
SARS COV-2 infection |
Symptoms |
Sputum production [Present vs. Not present] |
Odds ratio: 0.290 (0.100-0.720)
§ |
Sun
|
|
|
SARS COV-2 infection |
Symptoms |
Gastrointestinal symptoms [Present vs. Not present] |
Odds ratio: 2.690 (1.080-6.890)
§ |
Sun
|
|
|
SARS COV-2 infection |
Findings |
CXR/CT suggestive of pneumonia [Present vs. Not present] |
Odds ratio: 2.860 (1.090-7.690)
§ |
Sun
|
|
|
SARS COV-2 infection |
Laboratory Findings |
Neutrophils [1 unit increase vs. Not applicable] |
Odds ratio: 0.390 (0.260-0.540)
§ |
Sun
|
|
|
SARS COV-2 infection |
Laboratory Findings |
Eosinophils [1 unit increase vs. Not applicable] |
Odds ratio: 0.890 (0.830-0.940)
§ |
Sun
|
|
|
SARS COV-2 infection |
Laboratory Findings |
Creatinine [1 unit increase vs. Not applicable] |
Odds ratio: 0.960 (0.910-1.000)
§ |
Sun
|
|
|
SARS COV-2 infection |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 3.510 (0.970-13.890)
§ |
Sun
|
|
|
SARS COV-2 infection |
Symptoms |
Body temperature [1 unit increase vs. Not applicable] |
Odds ratio: 2.430 (1.250-5.020)
§ |
Sun
|
|
|
SARS COV-2 infection |
Vital Signs |
Heart rate [1 unit increase vs. Not applicable] |
Odds ratio: 0.960 (0.920-0.990)
§ |
Sun
|
|
|
SARS COV-2 infection |
Vital Signs |
Respiration rate [1 unit increase vs. Not applicable] |
Odds ratio: 1.300 (1.070-1.600)
§ |
Sun
|
|
|
SARS COV-2 infection |
Vital Signs |
Diastolic blood pressure [1 unit increase vs. Not applicable] |
Odds ratio: 1.050 (1.000-1.100)
§ |
Sun
|
|
|
SARS COV-2 infection |
Symptoms |
Sore throat [Present vs. Not present] |
Odds ratio: 0.630 (0.340-1.140)
§ |
Sun
|
|
|
SARS COV-2 infection |
Symptoms |
Sputum production [Present vs. Not present] |
Odds ratio: 0.300 (0.110-0.790)
§ |
Sun
|
|
|
SARS COV-2 infection |
Symptoms |
Gastrointestinal symptoms [Present vs. Not present] |
Odds ratio: 2.310 (0.920-5.930)
§ |
Sun
|
|
|
SARS COV-2 infection |
Laboratory Findings |
Neutrophils [1 unit increase vs. Not applicable] |
Odds ratio: 0.380 (0.250-0.530)
§ |
Sun
|
|
|
SARS COV-2 infection |
Laboratory Findings |
Eosinophils [1 unit increase vs. Not applicable] |
Odds ratio: 0.900 (0.840-0.960)
§ |
Sun
|
|
|
SARS COV-2 infection |
Laboratory Findings |
Creatinine [1 unit increase vs. Not applicable] |
Odds ratio: 0.960 (0.920-1.000)
§ |
Sun
|
|
|
SARS COV-2 infection |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 1.030 (1.020-1.050)
§ |
Sun
|
|
|
SARS COV-2 infection |
Symptoms |
Body temperature [1 unit increase vs. Not applicable] |
Odds ratio: 2.270 (1.500-3.440)
§ |
Sun
|
|
|
SARS COV-2 infection |
Vital Signs |
Heart rate [1 unit increase vs. Not applicable] |
Odds ratio: 0.970 (0.950-0.990)
§ |
Sun
|
|
|
SARS COV-2 infection |
Vital Signs |
Diastolic blood pressure [1 unit increase vs. Not applicable] |
Odds ratio: 1.030 (1.000-1.060)
§ |
Sun
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Cardiovascular disease [Present vs. Not present] |
Odds ratio: 3.890 (1.640-9.220)
|
Wang
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Cardiovascular disease [Present vs. Not present] |
Odds ratio: 2.930 (1.730-4.960)
|
Wang
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Chronic kidney disease [Present vs. Not present] |
Odds ratio: 2.510 (0.930-6.780)
|
Wang
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Cancer [Present vs. Not present] |
Odds ratio: 2.290 (1.000-5.230)
|
Wang
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Chronic liver disease [Present vs. Not present] |
Odds ratio: 0.670 (0.300-1.490)
|
Wang
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
COPD [Present vs. Not present] |
Odds ratio: 5.970 (2.490-14.290)
|
Wang
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Diabetes [Present vs. Not present] |
Odds ratio: 2.470 (1.670-3.660)
|
Wang
|
|
|
COVID-19 (severe/critical) |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 2.290 (1.690-3.100)
|
Wang
|
|
|
Prolonged duration of SARS-CoV-2 shedding |
Intervention |
Invasive mechanical ventilation [Used vs. Not used] |
Odds ratio: 9.880 (1.110-88.020)
§ |
Xu
|
|
|
Prolonged duration of SARS-CoV-2 shedding |
Status |
Severe illness [Present vs. Not present] |
Odds ratio: 1.100 (0.030-5.220)
§ |
Xu
|
|
|
Prolonged duration of SARS-CoV-2 shedding |
Status |
Time from symptom onset to hospital admission [1 day increase vs. Not applicable] |
Odds ratio: 1.300 (1.100-1.540)
§ |
Xu
|
|
|
Prolonged duration of SARS-CoV-2 shedding |
Treatment |
Treatment for COVID-19 [Treated with corticosteroid vs. Not received] |
Odds ratio: 1.380 (0.520-3.650)
§ |
Xu
|
|
|
Prolonged duration of SARS-CoV-2 shedding |
Comorbidities |
Hypertension [Present vs. Not present] |
Odds ratio: 3.940 (0.860-18.150)
§ |
Xu
|
|
|
Prolonged duration of SARS-CoV-2 shedding |
Patient characteristics |
Gender [Male vs. Female] |
Odds ratio: 3.240 (1.310-8.020)
§ |
Xu
|
|
|
Prolonged duration of SARS-CoV-2 shedding |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 1.000 (0.960-1.030)
§† |
Xu
|
|
|
Clinical resolution of symptoms |
Treatment |
Treatment for COVID-19 [Treated with corticosteroid vs. Not received] |
Hazard ratio: 0.860 (0.400-1.830)
|
Zha
|
|
|
Hospital discharge |
Treatment |
Treatment for COVID-19 [Treated with corticosteroid vs. Not received] |
Hazard ratio: 0.770 (0.330-1.780)
|
Zha
|
|
|
Virus clearance |
Treatment |
Treatment for COVID-19 [Treated with corticosteroid vs. Not received] |
Hazard ratio: 1.260 (0.580-2.740)
† |
Zha
|
|
|
COVID-19 (death) |
Laboratory Findings |
Cardiac troponin [Abnormal vs. Normal] |
Odds ratio: 4.080 (1.170-14.250)
§ |
Du
|
|
|
COVID-19 (death) |
Complications |
Acute kidney Injury [Stage 3 vs. Not present] |
Hazard ratio: 4.720 (2.550-8.750)
§ |
Cheng
|
|
|
COVID-19 (death) |
Complications |
Acute kidney Injury [Stage 3 vs. Not present] |
Hazard ratio: 9.810 (5.460-17.650)
|
Cheng
|
|
|
COVID-19 (death) |
Complications |
Acute kidney Injury [Stage 2 vs. Not present] |
Hazard ratio: 3.530 (1.500-8.270)
§ |
Cheng
|
|
|
COVID-19 (death) |
Complications |
Acute kidney Injury [Stage 2 vs. Not present] |
Hazard ratio: 6.240 (2.730-14.270)
|
Cheng
|
|
|
COVID-19 (death) |
Complications |
Acute kidney Injury [Stage 1 vs. Not present] |
Hazard ratio: 1.900 (0.760-4.750)
§ |
Cheng
|
|
|